Search: 2019 EU Faculty
Results 1 - 4 of 4

Anne Clare Wadsworth

Global Business Unit Head
Envision Pharma

Bio: Anne Clare brings a wealth of experience in healthcare communications from a 20 year career leading medical strategy and communication agencies. With a focus on innovation, Anne Clare has been at the forefront of transforming agency services, reflecting the ever-changing requirements of Medical Affairs and Publications teams within biopharmaceutical companies. Beginning her agency career at Gardiner-Caldwell Communications in 2000, Anne Clare supported clients across multiple therapy areas and product launches prior to joining Envision Pharma Group in 2016 as part of the senior leadership team. With a keen interest in patient engagement, Anne Clare has been a vocal advocate for tackling the lack of consistent and evidence-based practices for patient partnership within life science communications as well as exploring how patient advocates and medical affairs teams can work in partnership towards shared goals. Last year, Anne Clare in partnership with her colleague Professor Karen Woolley, launched a new centre of excellence within Envision Pharma Group dedicated to Patient Partnership in Medical Affairs and Publications. Comprising a team of industry experts, the Envision the Patient team are leading the industry debate on the removal of barriers for patients wanting access to high quality, fair-balance scientific content.

Al Weigel

President/CEO
ISMPP

Type of Company:
Other
Professional Degrees: CMPP, MEd
CMPP Certified: (2/2009)

Bio: Al Weigel is President and COO for the International Society for Medical Publication Professionals (ISMPP). Al joined ISMPP in November of 2013 with primary responsibility for implementing the strategic goals and vision of the Society, in addition to ensuring the Society meets established milestones for ongoing development, growth and success. Prior to joining ISMPP, Al led cross-therapeutic medical publication and scientific communication teams at sanofi-aventis, Boehringer-Ingelheim and Celgene Corporation. Al earned his Masters of Education at the University of the Arizona and currently is a ISMPP Certified Medical Publication Professional (CMPP).

Christopher Winchester

Chief Executive Officer
Oxford PharmaGenesis

Type of Company:
Communications Agency
Professional Degrees: BA/BS, PhD

Bio: Chris Winchester is Chief Executive Officer of Oxford PharmaGenesis, an independent HealthScience communications consultancy with a strong heritage in publications. Now in its 21st year, Oxford PharmaGenesis employs over 250 communications professionals in Europe, North America and Asia Pacific. Chris is Chair of ISMPP, a founder of Open Pharma, led the development of the AMWA-EMWA-ISMPP Joint Position Statement on the role of the professional medical writer, and has been involved in collaborative research on the value of professional medical writing support. He has a doctorate in Biochemistry, has co-authored articles in the fields of cardiology, gastroenterology and respiratory medicine, and is an Associate Member of Green Templeton College at the University of Oxford.

Robert Wright

Head, Clinical Data Transparency, Medical Governance and Ethics - CMO
Sanofi

Type of Company:
Pharmaceutical
Professional Degrees: PharmD

Bio: Bob graduated with a Doctor of Pharmacy (PharmD) degree from the University of Texas at Austin College of Pharmacy. He is currently the Head of Clinical Data Transparency in the Chief Medical Officer's Office at Sanofi. He and his team lead the company-wide policies and systems for publications and data sharing. Prior to joining Sanofi, he held a variety of US and Global medical affairs positions at Bristol-Myers Squibb and Astra Zeneca. In his 20 years of experience in the pharmaceutical industry, he has led several high priority brands across multiple therapeutic areas, including oncology, cardiovascular, and diabetes.